Heart Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults aged 18 or older of any sex
- People who are able to understand and sign a consent form agreeing to take part in the study and to allow their personal health data to be used
- People living with heart failure that is still causing symptoms despite already receiving the best available medical treatment
- People whose heart's left pumping chamber is not working at full strength (pumping less than 50% of its blood with each beat)
- People who have been assessed by their doctors as suitable for a device called a Cardiac Contractility Modulation (CCM) implant, based on current European heart failure guidelines
- People who have had at least one hospital admission, emergency department visit, or day hospital stay of more than 4 hours (for example, to receive heart medication through a drip) in the year before the implant
Who may not be able to join:
- People whose life expectancy is less than 1 year due to serious health conditions unrelated to their heart
- People for whom the CCM implant procedure is not medically suitable — for example, due to no usable blood vessel access, an active infection, a serious blood clotting disorder, or having a mechanical tricuspid heart valve
- People who cannot safely undergo a stress echocardiogram (a heart scan performed with the help of medication) — reasons for this may include active heart failure, a recent heart attack, active heart or surrounding tissue inflammation, severe narrowing of the aortic heart valve, a tear in the main artery, serious uncontrolled heart rhythm problems, a known allergy to the medication used, or blood clots inside the heart chambers
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Francesco Zanon, MD, UO Cardiologia, S. Maria della Misericordia Hospital, ULSS5 Polesana, Rovigo (I)
Phone: +39 049715373
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
New York Heart Association class variation
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.